Business Models in Neurotech
Neurotech Pub
When Do You Read?
When do you read? Do you read at night or early in the morning, or week ends? I think i'm similar to bryan. It's hard to get a time during the week and a nighty. And a, looking forward to some time off during the summer, i hopefulle'll have more reading time.
Welcome back to the Season 2 premiere of Neurotech Pub!
In this episode, host and Paradromics CEO Matt Angle sits down with fellow Founder/CEOs Carolina Aguilar, Brian Pepin, and Kunal Ghosh to talk shop about building cutting edge neurotech companies from the ground up. We dive deep into business strategies, the neurotech fundraising landscape, emerging therapeutics, and more. We also provide an insider’s view of the intersections of data, pharma, and med devices that are shaping the future of healthcare. Pour yourself a cold one and settle in!
Check out full video with transcript here: Check out video and a full episode transcript here.
00:00 | Updates & News
>> INBRAIN Neuroelectronics raised a $17M Series A
>> Rune Labs raised a $22.8 Million Series A
>> Inscopix Launched Cloud-Based Platform for Data Management and Analysis
2:15 | Meet the panel and pick up a book
1:54 | Jester King Brewery
2:25 | Rune Labs
2:50 | Neurostimulator for deep brain stimulation therapy
3:23 | INBRAIN Neuroelectronics
4:11 | Inscopix
5:24 | Ursula K. Le Guin’s 'The Dispossessed'
6:19 | Yuval Noah Harari’s 'Sapiens: A Brief History of Humankind'
6:32 | Daniel G. Miller’s 'The Tree of Knowledge'
6:40 | Jiddu Krishnamurti’s 'The Book of Life'
7:34 | Barack Obama’s 'A Promised Land,' ‘Dreams from my Father,’ & ‘The Audacity of Hope’ 7:56 | Karl Popper’s 'The Open Society and Its Enemies'
9:25 | Venture Capital in Neurotech
34:44 | Business Strategy in Neurotech
40:32 | Tom Oxley, CEO, Synchron
43:58 | Dr. Thomas Insel
44:06 | Mindstrong Mental Health Care
44:35 | Aduhelm controversy
52:25 | Galvani Bio
59:39 | Percept Neurostimulator
1:00:32 | Neuromodulation and the future of treating brain disease
1:07:21 | Software as a Medical Device FDA Guidance
1:09:12 | State of Animal Model Systems
1:14:28 | α-Synuclein in Parkinson's Disease
1:18:01 | Alto Neuroscience
1:18:36 | Flatiron Foundation
1:18:45 | Gaurdent Health
1:19:03 | Melanoma Trends & Rates
1:21:41 | The Pharma-Data-Device Ecosystem
1:21:42 | Frank Fischer, Chairman of Neuropace
1:22:28 | Neurotech Pub Season 1, Episode 9
1:26:35 | Roche acquisition of Flatiron Health & merger with Foundation Medicine
1:27:12 | Companion Diagnostics
1:28:29 | Adhulem and PET imaging
1:29:09 | Resignations at the FDA over Alzheimer’s Drug
1:29:32 | Derek Lowe’s take on the Aducanumab Approval, FDA Committee Votes, Halting the Aducanumab Trials, & The FDA Advisory Committee Briefing Document on Aducanumab
1:31:39 | Donanemab receives breakthrough therapy designation in 2021
1:36:58 | Mapping the Frontal-Vagal Pathway
1:37:09 | The Human Connectome Project
1:40:07 | Teal Organizations and Holacracy
1:41:18 | Society for Neuroscience
1:44:37 | Affymetrix (Thermo Fisher Scientific)
1:44:39 | Illumina
Want more?
Follow Paradromics & Neurotech Pub on Twitter
Follow Matt, Brian, Carolina, & Kunal on Twitter
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
The AI-powered Podcast Player
